Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
- PMID: 14762783
- DOI: 10.1053/j.gastro.2003.10.065
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
Abstract
Background & aims: An association between diabetes and chronic liver disease has been reported. However, the temporal relationship between these conditions remains unknown.
Methods: We identified all patients with a hospital discharge diagnosis of diabetes between 1985 and 1990 using the computerized records of the Department of Veterans Affairs. We randomly assigned 3 patients without diabetes for every patient with diabetes. We excluded patients with concomitant liver disease. The remaining cohort was followed through 2000 for the occurrence of chronic nonalcoholic liver disease (CNLD) and hepatocellular carcinoma (HCC). Hazard rate ratios (HRR) were determined in Cox proportional hazard survival analysis.
Results: The study cohort comprised 173,643 patients with diabetes and 650,620 patients without diabetes. Most were men (98%). Patients with diabetes were older (62 vs. 54 years) than patients without diabetes. The incidence of chronic nonalcoholic liver disease was significantly higher among patients with diabetes (incidence rate: 18.13 vs. 9.55 per 10,000 person-years, respectively, P < 0.0001). Similar results were obtained for HCC (incidence rate: 2.39 vs. 0.87 per 10,000 person-years, respectively, P < 0.0001). Diabetes was associated with an HRR of 1.98 (95% CI: 1.88 to 2.09, P < 0.0001) of CNLD and an HRR of 2.16 (1.86 to 2.52, P < 0.0001) of hepatocellular carcinoma. Diabetes carried the highest risk among patients with longer than 10 years of follow-up.
Conclusions: Among men with diabetes, the risk of CNLD and HCC is doubled. This increase in risk is independent of alcoholic liver disease, viral hepatitis, or demographic features.
Comment in
-
What every hepatologist should know about endocrinology: obesity, diabetes, and liver disease.Gastroenterology. 2004 Feb;126(2):604-6. doi: 10.1053/j.gastro.2003.12.018. Gastroenterology. 2004. PMID: 14762798 Review. No abstract available.
-
Is diabetes a risk factor for hepatocellular carcinoma?Gastroenterology. 2004 Jul;127(1):360-1; author reply 361-2. doi: 10.1053/j.gastro.2004.05.045. Gastroenterology. 2004. PMID: 15236219 No abstract available.
Similar articles
-
The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.Am J Gastroenterol. 2001 Aug;96(8):2462-7. doi: 10.1111/j.1572-0241.2001.04054.x. Am J Gastroenterol. 2001. PMID: 11513191
-
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.Gastroenterology. 2018 Dec;155(6):1828-1837.e2. doi: 10.1053/j.gastro.2018.08.024. Epub 2018 Aug 23. Gastroenterology. 2018. PMID: 30144434 Free PMC article.
-
Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort.J Natl Cancer Inst. 2010 Sep 8;102(17):1354-65. doi: 10.1093/jnci/djq301. Epub 2010 Aug 20. J Natl Cancer Inst. 2010. PMID: 20729477 Free PMC article.
-
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.Curr Diab Rep. 2007 Jun;7(3):175-80. doi: 10.1007/s11892-007-0029-z. Curr Diab Rep. 2007. PMID: 17547834 Review.
-
Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:88-92. doi: 10.1111/jgh.12239. J Gastroenterol Hepatol. 2013. PMID: 24251711 Review.
Cited by
-
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):330-44. doi: 10.1038/nrgastro.2013.41. Epub 2013 Mar 19. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23507799 Review.
-
Increased levels of serum leptin are a risk factor for the recurrence of stage I/II hepatocellular carcinoma after curative treatment.J Clin Biochem Nutr. 2011 Nov;49(3):153-8. doi: 10.3164/jcbn.10-149. Epub 2011 Oct 29. J Clin Biochem Nutr. 2011. PMID: 22128212 Free PMC article.
-
Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.Oncotarget. 2016 Aug 16;7(33):53820-53836. doi: 10.18632/oncotarget.10781. Oncotarget. 2016. PMID: 27462777 Free PMC article.
-
Association between diabetes mellitus and cirrhosis mortality: the Singapore Chinese Health Study.Liver Int. 2017 Feb;37(2):251-258. doi: 10.1111/liv.13241. Epub 2016 Sep 16. Liver Int. 2017. PMID: 27566448 Free PMC article.
-
Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives.Clinicoecon Outcomes Res. 2022 Sep 14;14:607-618. doi: 10.2147/CEOR.S371778. eCollection 2022. Clinicoecon Outcomes Res. 2022. PMID: 36127889 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical